Drugs / Dexamethasone tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00923273 Background | Feb 2008 → Mar 2013 | non-small cell lung carcinoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexamethasone tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00923273 ↗ |
| Route | Oral | “dexamethasone tablets twice a day the day before, the day of, and the day after pemetrexed infusions” NCT00923273 ↗ |